Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Deloitte
Julphar
Daiichi Sankyo
Boehringer Ingelheim
UBS
Dow
McKesson

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Ipilimumab

« Back to Dashboard

US Patents for Ipilimumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ipilimumab ➤ Try a Free Trial Compositions and methods of tumor treatment utilizing nanoparticles OP NANO CO., LTD. (Taipei, TW) TRENDMED CO., LTD. (Beitou Dist., Taipei, TW) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Encapsulated agents and methods of making and using thereof University of Georgia Research Foundation, Inc. (Athens, GA) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor Amgen Inc. (Thousand Oaks, CA) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Substituted urea derivatives and pharmaceutical uses thereof SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) ➤ Try a Free Trial
Ipilimumab ➤ Try a Free Trial Androgen receptor modulators and methods for their use British Columbia Cancer Agency Branch (Vancouver, CA) The University of British Columbia (Vancouver, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ipilimumab

Drugname Country Document Number Estimated Expiration Related US Patent
Ipilimumab Australia 2016219004 2035-02-13 ➤ Try a Free Trial
Ipilimumab Canada 2976526 2035-02-13 ➤ Try a Free Trial
Ipilimumab China 107921005 2035-02-13 ➤ Try a Free Trial
Ipilimumab European Patent Office 3256110 2035-02-13 ➤ Try a Free Trial
Ipilimumab Japan 2018505224 2035-02-13 ➤ Try a Free Trial
Ipilimumab South Korea 20170132152 2035-02-13 ➤ Try a Free Trial
Ipilimumab Philippines 12017501420 2035-02-13 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Cipla
Dow
Fuji
Federal Trade Commission
US Department of Justice
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.